Risk Assessment & Management Flashcards
7 cards from real CMC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Risk Assessment & Management flashcards as text
A 62-year-old man with hypertension and dyslipidemia presents for cardiovascular risk evaluation. His 10-year ASCVD risk is 9.5%. Which management step is most appropriate?
Answer: Engage in a risk discussion and consider statin therapy with moderate intensity
A 10-year ASCVD risk of 7.5–10% is in the borderline risk zone, warranting a clinician–patient risk discussion before initiating moderate-intensity statin therapy.
Which of the following 'risk-enhancing factors' can shift a borderline-risk patient toward initiating statin therapy per 2018 AHA/ACC guidelines?
Answer: hsCRP ≥ 2 mg/L
An hsCRP ≥ 2 mg/L is a recognized risk-enhancing factor that supports initiation of statin therapy in borderline-risk patients.
In the revised GRACE 2.0 ACS risk score, which variable contributes most to predicting 6-month mortality after hospitalization for ACS?
Answer: Age
Age is the single most heavily weighted variable in the GRACE score, reflecting the strong age-dependent increase in post-ACS mortality.
A patient's coronary artery calcium (CAC) score returns at 0. How does this result affect statin decision-making in a borderline-risk patient?
Answer: It supports withholding statin therapy and repeating in 5–10 years
A CAC score of 0 in a borderline-risk patient supports a decision to withhold statin therapy, as it indicates very low near-term atherosclerotic event risk.
Which cardiac biomarker, when elevated in a stable outpatient with heart failure, is most strongly associated with increased mortality risk?
Answer: Troponin I (high-sensitivity)
Elevated high-sensitivity troponin I in stable heart failure patients identifies subclinical myocardial injury and is independently associated with increased mortality.
According to the HAS-BLED score, which of the following increases bleeding risk in a patient on anticoagulation for atrial fibrillation?
Answer: History of major bleeding or predisposition
History of major bleeding or a bleeding predisposition is one of the components of HAS-BLED that adds 1 point and increases estimated bleeding risk.
A patient with NSTEMI has a TIMI risk score of 5. What does this score indicate regarding management?
Answer: High risk; early invasive strategy is recommended
A TIMI score of 5 (out of 7) indicates high risk, where early invasive strategy (angiography within 24–48 hours) is recommended to reduce adverse outcomes.